We are proud to announce that PhenoPath is now a Quest Diagnostics Company.

Menu

About PhenoPath
Test Menu
Diagnostic Services
BioPharma Services
News & Info
Contact Us
Educational Media

Company News

News & Info » Company News

PhenoPath launches first-ever NGS assay

Oncomine™ Dx Target Test (NGS)

News & Info
Company News
Publications
Upcoming Events
Newsletters

CAP Accredited
PhenoNet
Requisition Forms
Privacy
Terms
Privacy Shield
Cookie Notice
DO NOT SELL MY PERSONAL INFORMATION
Sitemap

Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000-2019 Quest Diagnostics Incorporated. All rights reserved.